Antibody–drug and other conjugates at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
18 organizations at PEGS Europe 2026 present work in antibody–drug and other conjugates: 9 suppliers and service providers, 8 drug developers and 1 academic, government or non-profit body. Between them they bring 20 presentations to the program. Most represented: Affilogic (2 on the program), Lonza (2 on the program), VERAXA Biotech (2 on the program). As of Oct 8, 2026.
Format
Top represented
Showing 1–16 of 18 organizations
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Affilogic Nantes, France | |
Develops Nanofitins, small non-antibody protein scaffolds, for targeted delivery and therapeutics. | Talk Wed Nov 18 11:15am–11:45am Panel Wed Nov 18 5:00pm–5:30pm Talk Thu Nov 19 11:15am–11:45am |
Lonza Basel, Switzerland | ◆Corporate Sponsor |
Contract development and manufacturing organisation for biologics and bioconjugates, and licensor of the GS CHO expression system. | Booth Exhibiting at Booth 204 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm Talk Wed Nov 18 3:05pm–3:35pm Talk Wed Nov 18 3:20pm–3:35pm |
VERAXA Biotech Heidelberg, Germany | |
Develops antibody-drug conjugates and bispecific T cell engagers for cancer, with its lead program in acute myeloid leukemia. | Talk Tue Nov 17 9:00am–9:30am Talk Wed Nov 18 7:00pm–7:30pm |
Biopharmaceutical consultancy advising on drug discovery, preclinical and clinical development, and in-licensing of early-stage assets. | Chair Wed Nov 18 8:25am–8:30am |
◆Corporate Sponsor | |
Contract development and manufacturing organization for antibodies and bioconjugates, including ADCs, from development to GMP supply. | Booth Exhibiting at Booth 303 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm |
Isogenica Cambridge, UK | ◆Corporate Sponsor |
VHH antibody discovery services built on synthetic VHH libraries and CIS display. | Booth Exhibiting at Booth 423 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm Talk Tue Nov 17 10:15am–10:30am |
◆Corporate Sponsor | |
Harbour BioMed subsidiary offering Harbour Mice transgenic antibody platforms and discovery services from target to IND. | Booth Exhibiting at Booth 215 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm Talk Tue Nov 17 10:00am–10:15am |
◆Corporate Sponsor | |
Contract research, development and manufacturing organization for antibody-drug conjugates and other bioconjugates, from linker-payload chemistry to GMP production. | Booth Exhibiting at Booth 228 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm Talk Wed Nov 18 12:15pm–12:45pm |
Aarhus University Aarhus, Denmark | |
Danish public research university. | Talk Wed Nov 18 2:35pm–3:05pm |
A AbTx Dijon, France | |
French start-up making smaller antibody fragment-drug conjugates for solid tumours with its enzymatic site-specific TheranoStick conjugation technology. | Talk Wed Nov 18 9:00am–9:30am |
CO Crossfire Oncology | |
Talk Wed Nov 18 6:30pm–7:00pm | |
Hexagon Bio Menlo Park, CA | |
Discovers new payload mechanisms for antibody-drug conjugates in cancer. | Talk Wed Nov 18 2:05pm–2:35pm |
Iksuda Therapeutics Newcastle upon Tyne, UK | |
Develops antibody-drug conjugates with novel payloads and linker chemistry for cancer. | Talk Wed Nov 18 6:00pm–6:30pm |
KT K2B Therapeutics | |
Develops bispecific antibody-drug conjugates for cancer, using its own discovery platform to find target pairs that favour tumour over healthy tissue. | Talk Wed Nov 18 11:45am–12:15pm |
Creative Biolabs Shirley, NY | ◆Corporate Support Sponsor |
Contract research provider offering antibody discovery, engineering and conjugation services, plus related reagents, across many therapeutic formats. | Booth Exhibiting at Booth 309 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm |
Instantly find 20 buyers in antibody–drug and other conjugates
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse PEGS Europe 2026 by
Organization type
Topic
- Discovery and display 80
- Protein and antibody engineering 39
- Bispecifics, multispecifics and T cell engagers 61
- Antibody–drug and other conjugates 18
- Machine learning for protein engineering 58
- Developability, stability and formulation 49
- Analytical characterisation 46
- Protein expression 65
- Oncology and immunotherapy 43
- Autoimmune disease 15
- Peptide drug discovery 14
Exhibit hall
Everyone
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction